Annual report
4534.TEDINET S100W7OB
Period2024-04-01 → 2025-03-31
Filed2025-06-27
StandardJapan GAAP
ConsolidatedYes
Data checks24 of 24 passed
Key figures · 148
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥105.2bn | 2024-04-01 → 2025-03-31 | Cons. | Net sales |
| Revenue | ¥102.9bn | 2023-04-01 → 2024-03-31 | Cons. | Net sales |
| Revenue | ¥103.3bn | 2022-04-01 → 2023-03-31v | Cons. | Net sales (5-year summary) |
| Revenue | ¥110.2bn | 2021-04-01 → 2022-03-31v | Cons. | Net sales (5-year summary) |
| Revenue | ¥103.0bn | 2020-04-01 → 2021-03-31d | Cons. | Net sales (5-year summary) |
| Operating income | ¥8.1bn | 2024-04-01 → 2025-03-31 | Cons. | Operating income |
| Operating income | ¥5.8bn | 2023-04-01 → 2024-03-31 | Cons. | Operating income |
| Ordinary income | ¥8.1bn | 2024-04-01 → 2025-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥6.0bn | 2023-04-01 → 2024-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥9.1bn | 2022-04-01 → 2023-03-31v | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥14.8bn | 2021-04-01 → 2022-03-31v | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥12.3bn | 2020-04-01 → 2021-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Profit before tax | ¥8.1bn | 2024-04-01 → 2025-03-31 | Cons. | Income before income taxes |
| Profit before tax | ¥6.2bn | 2023-04-01 → 2024-03-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥5.7bn | 2024-04-01 → 2025-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥4.5bn | 2023-04-01 → 2024-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥6.6bn | 2022-04-01 → 2023-03-31v | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥10.6bn | 2021-04-01 → 2022-03-31v | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥8.6bn | 2020-04-01 → 2021-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income | ¥5.7bn | 2024-04-01 → 2025-03-31 | Cons. | Profit loss |
| Net income | ¥4.5bn | 2023-04-01 → 2024-03-31 | Cons. | Profit loss |
| Total assets | ¥160.1bn | at 2025-03-31 | Cons. | Assets |
| Total assets | ¥158.8bn | at 2024-03-31 | Cons. | Assets |
| Total assets | ¥158.8bn | at 2023-03-31v | Cons. | Total assets (5-year summary) |
| Total assets | ¥163.1bn | at 2022-03-31v | Cons. | Total assets (5-year summary) |
| Total assets | ¥161.8bn | at 2021-03-31d | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥29.4bn | at 2025-03-31 | Cons. | Liabilities |
| Total liabilities | ¥30.8bn | at 2024-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥130.7bn | at 2025-03-31 | Cons. | Net assets |
| Net assets / equity | ¥128.0bn | at 2024-03-31 | Cons. | Net assets |
| Net assets / equity | ¥126.8bn | at 2023-03-31v | Cons. | Net assets |
| Net assets / equity | ¥128.6bn | at 2022-03-31v | Cons. | Net assets (5-year summary) |
| Net assets / equity | ¥127.0bn | at 2021-03-31d | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥45.2bn | at 2025-03-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥33.3bn | at 2024-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥48.2bn | at 2025-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥24.3bn | at 2024-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥38.0bn | at 2023-03-31v | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥40.5bn | at 2022-03-31v | Cons. | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥41.0bn | at 2021-03-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Operating cash flow | ¥9.4bn | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | −¥7.5bn | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥7.3bn | 2022-04-01 → 2023-03-31v | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥7.5bn | 2021-04-01 → 2022-03-31v | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥9.2bn | 2020-04-01 → 2021-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | ¥17.4bn | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | ¥74m | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥2.9bn | 2022-04-01 → 2023-03-31v | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥2.0bn | 2021-04-01 → 2022-03-31v | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥880m | 2020-04-01 → 2021-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | −¥2.9bn | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥6.4bn | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥6.9bn | 2022-04-01 → 2023-03-31v | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥6.0bn | 2021-04-01 → 2022-03-31v | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥5.1bn | 2020-04-01 → 2021-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥160.36 | 2024-04-01 → 2025-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥126.8 | 2023-04-01 → 2024-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥178.93 | 2022-04-01 → 2023-03-31v | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥277.39 | 2021-04-01 → 2022-03-31v | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥222.29 | 2020-04-01 → 2021-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| Net assets per share | ¥3,686.69 | at 2025-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥3,609.64 | at 2024-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥3,470.18 | at 2023-03-31v | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥3,424.21 | at 2022-03-31v | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥3,317.92 | at 2021-03-31d | Cons. | Net assets per share (5-year summary) |
| Equity ratio | 81.6% | at 2025-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 80.6% | at 2024-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 79.8% | at 2023-03-31v | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 78.9% | at 2022-03-31v | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 78.5% | at 2021-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| ROE | 4.4% | 2024-04-01 → 2025-03-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 3.6% | 2023-04-01 → 2024-03-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 5.2% | 2022-04-01 → 2023-03-31v | Cons. | Rate of return on equity (5-year summary) |
| ROE | 8.3% | 2021-04-01 → 2022-03-31v | Cons. | Rate of return on equity (5-year summary) |
| ROE | 6.9% | 2020-04-01 → 2021-03-31d | Cons. | Rate of return on equity (5-year summary) |
| Employees | 1,508 | at 2025-03-31 | Cons. | Number of employees |
| Employees | 1,522 | at 2024-03-31 | Cons. | Number of employees |
| Employees | 1,529 | at 2023-03-31v | Cons. | Number of employees |
| Employees | 1,544 | at 2022-03-31v | Cons. | Number of employees |
| Employees | 1,558 | at 2021-03-31d | Cons. | Number of employees |
| Revenue | ¥95.4bn | 2024-04-01 → 2025-03-31 | Standalone | Net sales |
| Revenue | ¥94.2bn | 2023-04-01 → 2024-03-31 | Standalone | Net sales |
| Revenue | ¥95.5bn | 2022-04-01 → 2023-03-31v | Standalone | Net sales (5-year summary) |
| Revenue | ¥102.4bn | 2021-04-01 → 2022-03-31v | Standalone | Net sales (5-year summary) |
| Revenue | ¥95.3bn | 2020-04-01 → 2021-03-31d | Standalone | Net sales (5-year summary) |
| Operating income | ¥5.5bn | 2024-04-01 → 2025-03-31 | Standalone | Operating income |
| Operating income | ¥3.2bn | 2023-04-01 → 2024-03-31 | Standalone | Operating income |
| Ordinary income | ¥7.6bn | 2024-04-01 → 2025-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥5.4bn | 2023-04-01 → 2024-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥9.0bn | 2022-04-01 → 2023-03-31v | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥13.5bn | 2021-04-01 → 2022-03-31v | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥11.6bn | 2020-04-01 → 2021-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥6.9bn | 2024-04-01 → 2025-03-31 | Standalone | Income before income taxes |
| Profit before tax | ¥5.5bn | 2023-04-01 → 2024-03-31 | Standalone | Income before income taxes |
| Net income | ¥5.4bn | 2024-04-01 → 2025-03-31 | Standalone | Profit loss |
| Net income | ¥4.7bn | 2023-04-01 → 2024-03-31 | Standalone | Profit loss |
| Net income | ¥7.3bn | 2022-04-01 → 2023-03-31v | Standalone | Net income loss (5-year summary) |
| Net income | ¥10.4bn | 2021-04-01 → 2022-03-31v | Standalone | Net income loss (5-year summary) |
| Net income | ¥9.0bn | 2020-04-01 → 2021-03-31d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥153.1bn | at 2025-03-31 | Standalone | Assets |
| Total assets | ¥152.2bn | at 2024-03-31 | Standalone | Assets |
| Total assets | ¥152.4bn | at 2023-03-31v | Standalone | Total assets (5-year summary) |
| Total assets | ¥156.8bn | at 2022-03-31v | Standalone | Total assets (5-year summary) |
| Total assets | ¥155.6bn | at 2021-03-31d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥24.7bn | at 2025-03-31 | Standalone | Liabilities |
| Total liabilities | ¥25.8bn | at 2024-03-31 | Standalone | Liabilities |
| Net assets / equity | ¥128.5bn | at 2025-03-31 | Standalone | Net assets |
| Net assets / equity | ¥126.3bn | at 2024-03-31 | Standalone | Net assets |
| Net assets / equity | ¥125.1bn | at 2023-03-31v | Standalone | Net assets |
| Net assets / equity | ¥126.4bn | at 2022-03-31v | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥124.9bn | at 2021-03-31d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥40.5bn | at 2025-03-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥28.9bn | at 2024-03-31 | Standalone | Cash and deposits |
| EPS (basic) | ¥151.87 | 2024-04-01 → 2025-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥130.27 | 2023-04-01 → 2024-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥195.1 | 2022-04-01 → 2023-03-31v | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥274.03 | 2021-04-01 → 2022-03-31v | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥232.56 | 2020-04-01 → 2021-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| Dividend per share | ¥80 | 2024-04-01 → 2025-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥80 | 2023-04-01 → 2024-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥80 | 2022-04-01 → 2023-03-31v | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥90 | 2021-04-01 → 2022-03-31v | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥90 | 2020-04-01 → 2021-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥3,623.58 | at 2025-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥3,563.63 | at 2024-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥3,424.59 | at 2023-03-31v | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥3,364.03 | at 2022-03-31v | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥3,263.57 | at 2021-03-31d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 83.9% | at 2025-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 83.0% | at 2024-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 82.1% | at 2023-03-31v | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 80.6% | at 2022-03-31v | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 80.3% | at 2021-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 4.2% | 2024-04-01 → 2025-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 3.7% | 2023-04-01 → 2024-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 5.8% | 2022-04-01 → 2023-03-31v | Standalone | Rate of return on equity (5-year summary) |
| ROE | 8.3% | 2021-04-01 → 2022-03-31v | Standalone | Rate of return on equity (5-year summary) |
| ROE | 7.4% | 2020-04-01 → 2021-03-31d | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 36,390,000 | at 2025-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 37,470,000 | at 2024-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 38,500,000 | at 2023-03-31v | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 40,160,000 | at 2022-03-31v | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 40,630,000 | at 2021-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 1,237 | at 2025-03-31 | Standalone | Number of employees |
| Employees | 1,247 | at 2024-03-31 | Standalone | Number of employees |
| Employees | 1,252 | at 2023-03-31v | Standalone | Number of employees |
| Employees | 1,280 | at 2022-03-31v | Standalone | Number of employees |
| Employees | 1,298 | at 2021-03-31d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
All source rows · 1,425
| Item | Context | Value | Unit |
|---|---|---|---|
| Telephone number address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)03(3358)7211(代表) | |
| Name of contact person address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)経理部長 宮本 憲一 | |
| Nearest place of contact cover page | FilingDateInstant | Original text (Japanese)東京都新宿区四谷一丁目7番地 | |
| Telephone number nearest place of contact cover page | FilingDateInstant | Original text (Japanese)03(3358)7211(代表) | |
| Name of contact person nearest place of contact cover page | FilingDateInstant | Original text (Japanese)経理部長 宮本 憲一 | |
| Place for public inspection cover page (text) | FilingDateInstant | Text · Plus | |
| Edinet code | FilingDateInstant | E00947 | |
| Fund code | FilingDateInstant | － | |
| Security code | FilingDateInstant | 45340 | |
| Filer name in japanese | FilingDateInstant | Original text (Japanese)持田製薬株式会社 | |
| Filer name in english | FilingDateInstant | Mochida Pharmaceutical Co.,Ltd. | |
| Fund name in japanese | FilingDateInstant | － | |
| Fund name in english | FilingDateInstant | － | |
| Cabinet office ordinance | FilingDateInstant | Original text (Japanese)企業内容等の開示に関する内閣府令 | |
| Document type | FilingDateInstant | Original text (Japanese)第三号様式 | |
| Accounting standards | FilingDateInstant | Japan GAAP | |
| Whether consolidated financial statements are prepared | FilingDateInstant | true | |
| Industry code when consolidated financial statements are prepared in accordance with industry specific regulations | FilingDateInstant | cte | |
| Industry code when financial statements are prepared in accordance with industry specific regulations | FilingDateInstant | cte | |
| Current fiscal year start date | FilingDateInstant | 2024-04-01 | |
| Current period end date | FilingDateInstant | 2025-03-31 | |
| Type of current period | FilingDateInstant | FY | |
| Current fiscal year end date | FilingDateInstant | 2025-03-31 | |
| Previous fiscal year start date | FilingDateInstant | 2023-04-01 | |
| Comparative period end date | FilingDateInstant | 2024-03-31 | |
| Previous fiscal year end date | FilingDateInstant | 2024-03-31 | |
| Next fiscal year start date | FilingDateInstant | － | |
| End date of quarterly or semi annual period of next fiscal year | FilingDateInstant | － | |
| Amendment flag | FilingDateInstant | false | |
| Identification of document subject to amendment | FilingDateInstant | － | |
| Report amendment flag | FilingDateInstant | false | |
| Xbrl amendment flag | FilingDateInstant | false | |
| Business results of group (text) | FilingDateInstant | Text · Plus | |
| Business results of reporting company (text) | FilingDateInstant | Text · Plus | |
| Company history (text) | FilingDateInstant | Text · Plus | |
| Description of business (text) | FilingDateInstant | Text · Plus | |
| Overview of affiliated entities (text) | FilingDateInstant | Text · Plus | |
| Information about employees (text) | FilingDateInstant | Text · Plus | |
| Consolidated subsidiaries metrics of consolidated subsidiaries | CurrentYearInstant_Row1Member | Original text (Japanese)持田製薬工場㈱ | |
| Consolidated subsidiaries metrics of consolidated subsidiaries | CurrentYearInstant_Row2Member | Original text (Japanese)持田ヘルスケア㈱ | |
| Business policy business environment issues to address etc (text) | FilingDateInstant | Text · Plus | |
| Disclosure of sustainability related financial information (text) | FilingDateInstant | Text · Plus | |
| Governance (text) | FilingDateInstant | Text · Plus | |
| Risk management (text) | FilingDateInstant | Text · Plus | |
| Strategy climate change (text) | FilingDateInstant | Text · Plus | |
| Metrics and targets climate change (text) | FilingDateInstant | Text · Plus | |
| Reference to other information metrics and targets climate change | FilingDateInstant | Original text (Japanese)ESGデータ集 | |
| Strategy human capital diversity (text) | FilingDateInstant | Text · Plus | |
| Policy on development of human resources and internal environment strategy (text) | FilingDateInstant | Text · Plus | |
| Metrics and targets human capital diversity (text) | FilingDateInstant | Text · Plus |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 24 of 24 passed
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |